Almac: High-Throughput, High-Quality DNA and RNA Sequencing
When you are running an important biomarker project you need reassurance that your precious clinical trial samples will be handled carefully and that appropriate processing of clinical specimens in the lab is critical to the downstream sequencing success and data generation for Biomarker Projects.
We understand the importance of sample management. From sample in, to data out, you can trust Almac to carefully look after your samples for your clinical trials and provide a range of Genomic Services that deliver high-throughput, high-quality genomic data from DNA and RNA.
We Offer
High-Quality Data Output
- Higher QC Pass Rate
- Higher Detection & Reads
- Experience with Challenging Sample Types & Low Inputs
Carefully Managed Samples
- Dedicated Sample Management Team
- Ensuring Full Sample Traceability & No Breaks in Chain Of Custody
UK / US & China Laboratories
- Almac UK and US Laboratories with significant NGS experience
- Longstanding China Lab Partnerships to aid Global Studies
Dedicated Project Management Team
- PhD qualified, who understand scientific project requirements
- Respond to all queries in 24 hours
- Provide a high level of service and support
Almac Take Care of Your Precious Clinical Trial Samples
Almac’s dedicated Sample Management Team ensure that there is full sample traceability from the moment the samples are received at our sites, ensuring that there are no breaks in the chain of custody.
Importantly, Almac focus on quality and incorporate a range of QC checks throughout the sample lifecycle. From the initial stages of reception at Almac; assessing package integrity, sample integrity and sample suitability for processing.
Choose Almac
If you need a partner, who ensures the best quality data from your precious samples being handled and processed with the utmost of care for your biomarker project, choose Almac.
Contact Us
Interested in our high-throughput, high-quality sequencing services?
Simply get in touch below and an Almac representative will reach out to discuss your next biomarker project: